newsfilter
← Latest News
GlobeNewswire·

Aprea Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference

DOYLESTOWN, Pa., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (NASDAQ:APRE) ("Aprea" or the "Company"), a clinical-stage biopharmaceutical company developing innovative therapies that exploit